Leiden Institute of Chemistry and The Institute for Chemical Immunology, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
Bioorg Med Chem Lett. 2019 Jun 1;29(11):1340-1344. doi: 10.1016/j.bmcl.2019.03.048. Epub 2019 Mar 30.
Covalent linking of immunogenic oligopeptides with synthetic Toll-like receptor ligands is a useful approach to develop self-adjuvanting vaccines. In particular, small-molecule based agonists of Toll-like receptor 7 (TLR7) that are derived from 8-oxo-adenine core are potentially promising because these chemically robust TLR7 ligands can be connected to peptide T-cell epitopes via straightforward solid-phase peptide synthesis. In this contribution we present the synthesis of a Boc-protected 9-benzyl-2-alkoxy-8-oxo-adenine building block and its application in the online solid phase synthesis of three peptide conjugates that differ in the position of the TLR7 ligand within the peptide. The conjugates are able to induce dendritic cell maturation and T cell proliferation while the position of the ligand impacts T cell proliferation potency.
将免疫原性寡肽与合成 Toll 样受体配体共价连接是开发自佐剂疫苗的一种有效方法。特别是,衍生自 8-氧代腺嘌呤核心的基于小分子的 Toll 样受体 7(TLR7)激动剂具有很大的应用潜力,因为这些化学稳定的 TLR7 配体可以通过简单的固相肽合成与肽 T 细胞表位连接。在本研究中,我们介绍了 Boc 保护的 9-苄基-2-烷氧基-8-氧代腺嘌呤砌块的合成及其在三种肽缀合物的在线固相合成中的应用,这三种肽缀合物在 TLR7 配体在肽中的位置上有所不同。这些缀合物能够诱导树突状细胞成熟和 T 细胞增殖,而配体的位置则影响 T 细胞增殖能力。